Logo image of DXC

DXC TECHNOLOGY CO (DXC) Stock Fundamental Analysis

NYSE:DXC - New York Stock Exchange, Inc. - US23355L1061 - Common Stock - Currency: USD

16.77  +0.52 (+3.2%)

After market: 16.77 0 (0%)

Fundamental Rating

4

Taking everything into account, DXC scores 4 out of 10 in our fundamental rating. DXC was compared to 82 industry peers in the IT Services industry. Both the profitability and financial health of DXC have multiple concerns. DXC is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year DXC was profitable.
DXC had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DXC reported negative net income in multiple years.
In the past 5 years DXC always reported a positive cash flow from operatings.
DXC Yearly Net Income VS EBIT VS OCF VS FCFDXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

DXC has a Return On Assets of -0.58%. This is comparable to the rest of the industry: DXC outperforms 42.68% of its industry peers.
DXC has a Return On Equity (-2.51%) which is comparable to the rest of the industry.
DXC has a Return On Invested Capital of 3.54%. This is comparable to the rest of the industry: DXC outperforms 54.88% of its industry peers.
DXC had an Average Return On Invested Capital over the past 3 years of 2.21%. This is significantly below the industry average of 22.23%.
The 3 year average ROIC (2.21%) for DXC is below the current ROIC(3.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.58%
ROE -2.51%
ROIC 3.54%
ROA(3y)0.21%
ROA(5y)-4.14%
ROE(3y)0.4%
ROE(5y)-22.8%
ROIC(3y)2.21%
ROIC(5y)N/A
DXC Yearly ROA, ROE, ROICDXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

DXC's Profit Margin has declined in the last couple of years.
DXC has a Operating Margin (4.19%) which is in line with its industry peers.
DXC's Operating Margin has declined in the last couple of years.
The Gross Margin of DXC (23.92%) is worse than 69.51% of its industry peers.
DXC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.19%
PM (TTM) N/A
GM 23.92%
OM growth 3YN/A
OM growth 5Y-23.65%
PM growth 3YN/A
PM growth 5Y-35.7%
GM growth 3Y3.25%
GM growth 5Y-4.17%
DXC Yearly Profit, Operating, Gross MarginsDXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DXC is destroying value.
The number of shares outstanding for DXC has been reduced compared to 1 year ago.
DXC has less shares outstanding than it did 5 years ago.
The debt/assets ratio for DXC is higher compared to a year ago.
DXC Yearly Shares OutstandingDXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
DXC Yearly Total Debt VS Total AssetsDXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

DXC has an Altman-Z score of 1.04. This is a bad value and indicates that DXC is not financially healthy and even has some risk of bankruptcy.
DXC has a Altman-Z score of 1.04. This is in the lower half of the industry: DXC underperforms 67.07% of its industry peers.
The Debt to FCF ratio of DXC is 5.24, which is a neutral value as it means it would take DXC, 5.24 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DXC (5.24) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.22 is on the high side and indicates that DXC has dependencies on debt financing.
With a Debt to Equity ratio value of 1.22, DXC is not doing good in the industry: 68.29% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 5.24
Altman-Z 1.04
ROIC/WACC0.43
WACC8.29%
DXC Yearly LT Debt VS Equity VS FCFDXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

DXC has a Current Ratio of 1.34. This is a normal value and indicates that DXC is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DXC (1.34) is worse than 62.20% of its industry peers.
A Quick Ratio of 1.34 indicates that DXC should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.34, DXC is doing worse than 60.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34
DXC Yearly Current Assets VS Current LiabilitesDXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

3

3. Growth

3.1 Past

DXC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.56%, which is quite good.
DXC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.65% yearly.
The Revenue has decreased by -5.65% in the past year.
DXC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.01% yearly.
EPS 1Y (TTM)10.56%
EPS 3Y9.27%
EPS 5Y-17.65%
EPS Q2Q%5.75%
Revenue 1Y (TTM)-5.65%
Revenue growth 3Y-8.31%
Revenue growth 5Y-8.01%
Sales Q2Q%-5.12%

3.2 Future

DXC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.69% yearly.
DXC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.51% yearly.
EPS Next Y6.68%
EPS Next 2Y4.28%
EPS Next 3Y3.54%
EPS Next 5Y4.69%
Revenue Next Year-5.96%
Revenue Next 2Y-4.81%
Revenue Next 3Y-3.88%
Revenue Next 5Y-3.51%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DXC Yearly Revenue VS EstimatesDXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B
DXC Yearly EPS VS EstimatesDXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

8

4. Valuation

4.1 Price/Earnings Ratio

DXC is valuated cheaply with a Price/Earnings ratio of 4.71.
97.56% of the companies in the same industry are more expensive than DXC, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 24.83. DXC is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 4.87, which indicates a rather cheap valuation of DXC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DXC indicates a rather cheap valuation: DXC is cheaper than 96.34% of the companies listed in the same industry.
DXC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.94.
Industry RankSector Rank
PE 4.71
Fwd PE 4.87
DXC Price Earnings VS Forward Price EarningsDXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DXC indicates a rather cheap valuation: DXC is cheaper than 95.12% of the companies listed in the same industry.
97.56% of the companies in the same industry are more expensive than DXC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.15
EV/EBITDA 2.66
DXC Per share dataDXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.71
PEG (5Y)N/A
EPS Next 2Y4.28%
EPS Next 3Y3.54%

0

5. Dividend

5.1 Amount

No dividends for DXC!.
Industry RankSector Rank
Dividend Yield N/A

DXC TECHNOLOGY CO

NYSE:DXC (5/12/2025, 8:14:34 PM)

After market: 16.77 0 (0%)

16.77

+0.52 (+3.2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)05-14 2025-05-14/amc
Inst Owners95.6%
Inst Owner Change-9.75%
Ins Owners0.64%
Ins Owner Change-1.34%
Market Cap3.04B
Analysts50
Price Target21.46 (27.97%)
Short Float %3.58%
Short Ratio3.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.1%
Min EPS beat(2)18.16%
Max EPS beat(2)28.05%
EPS beat(4)4
Avg EPS beat(4)22.22%
Min EPS beat(4)15.96%
Max EPS beat(4)28.05%
EPS beat(8)6
Avg EPS beat(8)9.7%
EPS beat(12)8
Avg EPS beat(12)5.53%
EPS beat(16)11
Avg EPS beat(16)5.54%
Revenue beat(2)1
Avg Revenue beat(2)-0.73%
Min Revenue beat(2)-1.74%
Max Revenue beat(2)0.28%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.74%
Max Revenue beat(4)2.02%
Revenue beat(8)3
Avg Revenue beat(8)-0.83%
Revenue beat(12)3
Avg Revenue beat(12)-1.11%
Revenue beat(16)4
Avg Revenue beat(16)-1.03%
PT rev (1m)-6.47%
PT rev (3m)-3.74%
EPS NQ rev (1m)0.35%
EPS NQ rev (3m)4.22%
EPS NY rev (1m)0.03%
EPS NY rev (3m)5.53%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)-3.01%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE 4.71
Fwd PE 4.87
P/S 0.23
P/FCF 4.15
P/OCF 2.23
P/B 1.02
P/tB 4.43
EV/EBITDA 2.66
EPS(TTM)3.56
EY21.23%
EPS(NY)3.45
Fwd EY20.55%
FCF(TTM)4.04
FCFY24.08%
OCF(TTM)7.53
OCFY44.89%
SpS72.29
BVpS16.51
TBVpS3.79
PEG (NY)0.71
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.58%
ROE -2.51%
ROCE 5.94%
ROIC 3.54%
ROICexc 4.35%
ROICexgc 6.27%
OM 4.19%
PM (TTM) N/A
GM 23.92%
FCFM 5.59%
ROA(3y)0.21%
ROA(5y)-4.14%
ROE(3y)0.4%
ROE(5y)-22.8%
ROIC(3y)2.21%
ROIC(5y)N/A
ROICexc(3y)2.64%
ROICexc(5y)N/A
ROICexgc(3y)4.02%
ROICexgc(5y)N/A
ROCE(3y)3.75%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-33.14%
ROICexc growth 3YN/A
ROICexc growth 5Y-17.99%
OM growth 3YN/A
OM growth 5Y-23.65%
PM growth 3YN/A
PM growth 5Y-35.7%
GM growth 3Y3.25%
GM growth 5Y-4.17%
F-Score7
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 5.24
Debt/EBITDA 1.91
Cap/Depr 46.75%
Cap/Sales 4.83%
Interest Coverage 1.97
Cash Conversion 71.7%
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z 1.04
F-Score7
WACC8.29%
ROIC/WACC0.43
Cap/Depr(3y)43.15%
Cap/Depr(5y)42.53%
Cap/Sales(3y)4.6%
Cap/Sales(5y)4.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.56%
EPS 3Y9.27%
EPS 5Y-17.65%
EPS Q2Q%5.75%
EPS Next Y6.68%
EPS Next 2Y4.28%
EPS Next 3Y3.54%
EPS Next 5Y4.69%
Revenue 1Y (TTM)-5.65%
Revenue growth 3Y-8.31%
Revenue growth 5Y-8.01%
Sales Q2Q%-5.12%
Revenue Next Year-5.96%
Revenue Next 2Y-4.81%
Revenue Next 3Y-3.88%
Revenue Next 5Y-3.51%
EBIT growth 1Y161.96%
EBIT growth 3YN/A
EBIT growth 5Y-29.77%
EBIT Next Year108.47%
EBIT Next 3Y24.91%
EBIT Next 5Y18.12%
FCF growth 1Y1205.36%
FCF growth 3YN/A
FCF growth 5Y-1.87%
OCF growth 1Y77.94%
OCF growth 3Y181.52%
OCF growth 5Y-5.26%